BioAge Labs (BIOA) Total Liabilities (2023 - 2026)
BioAge Labs (BIOA) reported Total Liabilities of $18.5 million for Q1 2026, down 39.58% on a YoY basis from $30.7 million in Q1 2025, and down 18.85% sequentially from $22.8 million in Q4 2025.
BioAge Labs (BIOA) Total Liabilities (2023 - 2026) Analysis & Trends
BioAge Labs (BIOA) has 4 years of Total Liabilities data on file, last reported at $18.5 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities fell 39.58% year-over-year to $18.5 million; the trailing twelve-month figure through Mar 2026 stood at $18.5 million (down 39.58% YoY), and the FY2025 full-year result was $22.8 million, down 34.95% from the prior year.
- Total Liabilities retreated to $18.5 million in Q1 2026, from $22.8 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $66.6 million in Q4 2023 to a low of $18.5 million in Q1 2026.
- A 4-year average of $31.5 million and a median of $27.5 million in 2025 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities slumped 47.29% in 2024 and rose 16.9% in 2025, its largest moves.
- Tracing BIOA's Total Liabilities over 4 years: stood at $66.6 million in 2023, then sank by 47.29% to $35.1 million in 2024, then sank by 34.95% to $22.8 million in 2025, then slipped by 18.85% to $18.5 million in 2026.
- Business Quant data shows BIOA's Total Liabilities at $18.5 million in Q1 2026, $22.8 million in Q4 2025, and $27.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | BioAge Labs | 930.32 Mn | 930.32 Mn | -10.37 Mn | 18.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.53 Mn |
| Dec 31, 2025 | 22.84 Mn |
| Sep 30, 2025 | 27.63 Mn |
| Jun 30, 2025 | 27.37 Mn |
| Mar 31, 2025 | 30.67 Mn |
| Dec 31, 2024 | 35.11 Mn |
| Sep 30, 2024 | 23.63 Mn |
| Dec 31, 2023 | 66.60 Mn |